Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 11 more quarters, back to Sep 2022, with Tormere Pro.
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing — Yahoo Finance · 2026-09-18
Life Sciences Virtual Investor Forum Agenda Announced — Yahoo Finance · 2026-09-14
Adaptin Bio Opens Phase 1 Trial of Brain-Penetrant Bispecific T-Cell Engager APTN-101 in Glioblastoma — BioPharm International · 2026-08-21
Adaptin Bio Announces Opening of Enrollment in a Phase 1 Clinical Trial Evaluating Treatment of Malignant Brain Tumors with APTN-101 — Yahoo Finance · 2026-08-20
Tormere — informational purposes only, not investment advice.